Copolymerization of recombinant Phascolopsisgouldii hemerythrin with human serum albumin for use in blood substitutes

References

• Alayash AI. 2004. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov. 3:152–159.
   PubMed Web of Science ®Google Scholar
• Bassan A, Blomberg MRA, Siegbahn PEM. 2004. A theoretical study of the cis-dihydroxylation mechanism in naphthalene 1,2-dioxygenase. J Biol Inorg Chem. 9:439–452.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2004. Hemoglobin-based red blood cell substitutes. Artif Organs. 28:789–794.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2009. Nanobiotechnology for hemoglobin-based blood substitutes. Crit Care Clin. 25:373–382.
   PubMed Web of Science ®Google Scholar
• Cooper CE, Silaghi-Dumitrescu R, Rukengwa M, Alayash AI, Buehler PW. 2008. Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC). Biochim Biophys Acta 1784:1415–1420.
   PubMed Web of Science ®Google Scholar
• Eike JH, Palmer AF. 2004. Effect of Cl- and H + on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes. Biotechnol Prog. 20:1543–1549.
   PubMed Web of Science ®Google Scholar
• Farmer CS, Kurtz DM, Liu ZJ, Wang BC, Rose J, Ai J, et al. 2001. The crystal structures of Phascolopsis gouldii wild type and L98Y methemerythrins: structural and functional alterations of the O2 binding pocket. J Biol Inorg Chem. 6:418–429.
   PubMed Web of Science ®Google Scholar
• Farmer CS, Kurtz DM, Phillips RS, Ai J, Sanders-Loehr J. 2000. A leucine residue “gates” solvent but not O2 access to the binding pocket of Phascolopsis gouldii hemerythrin. J Biol Chem. 275:17043–17050.
   PubMed Web of Science ®Google Scholar
• Fischer-Fodor E, Mot A, Deac F, Arkosi M, Silaghi-Dumitrescu R. 2011. Towards hemerythrin-based blood substitutes: comparative performance to hemoglobin on human leukocytes and umbilical vein endothelial cells. J Biosci. 36:215–221.
   PubMed Web of Science ®Google Scholar
• Herold S, Exner M, Nauser T. 2001. Kinetic and mechanistic studies of the NO-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry 40:3385–3395.
   PubMed Web of Science ®Google Scholar
• Herold S. 1999. Kinetic and spectroscopic characterization of an intermediate peroxynitrite complex in the nitrogen monoxide induced oxidation of oxyhemoglobin. FEBS Lett. 443:81–84.
   PubMed Web of Science ®Google Scholar
• Iacob B, Deac F, Cioloboc D, Damian G, Silaghi-Dumitrescu R. 2011. Hemoglobin-albumin crosslinked copolymers: reduced prooxidant reactivity. Artif Cells Blood Substit Immobil Biotechnol. 39:293–297.
   PubMed Web of Science ®Google Scholar
• Jin S, Kurtz DM, Liu ZJ, Rose J, Wang BC. 2002. X-ray crystal structures of reduced rubrerythrin and its azide adduct: a structure-based mechanism for a non-heme diiron peroxidase. J Am Chem Soc. 124:9845–9855.
   PubMed Web of Science ®Google Scholar
• Kryatov SV, Rybak-Akimova EV, Schindler S. 2005. Kinetics and mechanisms of formation and reactivity of non-heme iron oxygen intermediates. Chem Rev. 105:2175–2226.
   PubMed Web of Science ®Google Scholar
• Kurtz DM. 1999. Oxygen-carrying proteins: three solutions to a common problem. Essays Biochem. 34:85–100.
   PubMed Web of Science ®Google Scholar
• Mot AC, Roman A, Lupan I, Kurtz DM, Silaghi-Dumitrescu R. 2010. Towards the development of hemerythrin-based blood substitutes. Protein J. 29:387–393.
   PubMed Web of Science ®Google Scholar
• Nocek JM, Kurtz DM, Pickering RA, Doyle MP. 1984. Oxidation of deoxyhemerythrin to semi-methemerythrin by nitrite. J Biol Chem. 259:12334–12338.
   PubMed Web of Science ®Google Scholar
• Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD. 2004. NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med. 36:685–697.
   PubMed Web of Science ®Google Scholar
• Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE, et al. 2008. Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J Biol Chem. 283:30780–30787.
   PubMed Web of Science ®Google Scholar
• Silaghi-Dumitrescu R, Silaghi-Dumitrescu I. 2006. DFT and the electromerism in complexes of iron with diatomic ligands. J Inorg Biochem. 100:161–166.
   PubMed Web of Science ®Google Scholar
• Tomita D, Kimura T, Hosaka H, Daijima Y, Haruki R, Ludwig K, et al. 2013. Covalent core-shell architecture of hemoglobin and human serum albumin as an artificial O2 carrier. Biomacromolecules 14:1816–1825.
   PubMed Web of Science ®Google Scholar
• Tsuchida E, Sou K, Nakagawa A, Sakai H, Komatsu T, Kobayashi K. 2009. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjug Chem. 20:1419–1440.
   PubMed Web of Science ®Google Scholar
• Winslow RM. 2004. MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugate. Artif Organs. 28:800–806.
   PubMed Web of Science ®Google Scholar